Literature DB >> 26978550

Cross reactivity of S. aureus to murine cytokine assays: A source of discrepancy.

Numan Javed1, Guang Xue2, Ailing Lu2, Yue Xing2, Yoichiro Iwakura3, Hui Xiao2, Hervé Lecoeur4, Gerald F Späth5, Guangxun Meng6.   

Abstract

Staphylococcus aureus is one of the versatile Gram positive bacteria causing a range of diseases. Upon challenge, host immune cells recognize S. aureus and mount diverse immune responses including production of pro-inflammatory cytokines such as IL-1β and TNF-α. These cytokines are important mediators of inflammation which can be detected via various immunological methods such as enzyme linked immunosorbent assay (ELISA) and immunoblotting. In the current study, we found that a number of clinical isolates as well as laboratory strains of S. aureus exhibited cross reactivity with ELISA antibodies for murine IL-1β and TNF-α assays. This cross reactivity generates exaggerated false positive signals which can be a source of discrepancy for the understanding of real immune responses against S. aureus infection by host immune cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cross reactivity; IL-1β; Inflammasome; S. aureus; TNF-α

Mesh:

Substances:

Year:  2016        PMID: 26978550     DOI: 10.1016/j.cyto.2016.03.007

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

1.  Type I IFN operates pyroptosis and necroptosis during multidrug-resistant A. baumannii infection.

Authors:  Yang Li; Xiaomin Guo; Chunmiao Hu; Yan Du; Chuansheng Guo; Weiheng Zhao; Gonghua Huang; Chunliang Li; Qiumin Lu; Ren Lai; Tao Xu; Xiaopeng Qi
Journal:  Cell Death Differ       Date:  2018-01-19       Impact factor: 15.828

2.  Protein A-Mediated Binding of Staphylococcus spp. to Antibodies in Flow Cytometric Assays and Reduction of This Binding by Using Fc Receptor Blocking Reagent.

Authors:  Ultan P Cronin; Laura Girardeaux; Elaine O'Meara; Martin G Wilkinson
Journal:  Appl Environ Microbiol       Date:  2020-08-18       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.